ETON – eton pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026
Eton Pharmaceuticals (ETON) had its price target raised by Craig Hallum from $29.00 to $30.00. They now have a "buy" rating on the stock.
Eton Pharmaceuticals (ETON) had its price target raised by HC Wainwright from $35.00 to $37.00. They now have a "buy" rating on the stock.
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution [Yahoo! Finance]
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution
Form 8-K Eton Pharmaceuticals, For: Feb 27
Form 8-K Eton Pharmaceuticals, For: Feb 25
Form 4 Eton Pharmaceuticals, For: Feb 03 Filed by: RIEDEL NORBERT G
Form 8-K Eton Pharmaceuticals, For: Feb 02
Form 4 Eton Pharmaceuticals, For: Jan 12 Filed by: RIEDEL NORBERT G
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.